Cargando…
Evaluation of aflibercept and ziv-aflibercept binding affinity to vascular endothelial growth factor, stability and sterility after compounding
PURPOSE: To investigate the binding affinity, stability, and sterility of aflibercept and ziv-aflibercept to vascular endothelial growth factor (Holash et al. in Proc Natl Acad Sci USA 99(17):11393–11398, 2002. 10.1073/pnas.172398299) after compounding and storage for up to 28 days at 4 °C and − 8 °...
Autores principales: | de Lima Farah, Julia, Sano, Ronaldo, Maugéri, Ieda Maria Longo, Teixeira, Daniela, Ishimura, Mayari Eika, Martins, Gabriela, Mimica, Lycia M. J., da Silva, Cely Barreto, Meyer, Carsten H., de Oliveira Dias, João Rafael, de Andrade, Gabriel Costa, Farah, Michel Eid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199727/ https://www.ncbi.nlm.nih.gov/pubmed/30386633 http://dx.doi.org/10.1186/s40942-018-0143-x |
Ejemplares similares
-
Fusion proteins for treatment of retinal diseases: aflibercept, ziv-aflibercept, and conbercept
por: de Oliveira Dias, João Rafael, et al.
Publicado: (2016) -
Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage
por: Mansour, Ahmad M., et al.
Publicado: (2020) -
The sterility, stability and efficacy of repackaged ziv-aflibercept for intravitreal administration
por: Juhong, Jakkrit, et al.
Publicado: (2022) -
Ziv-aflibercept in macular disease
por: Mansour, Ahmad M, et al.
Publicado: (2015) -
Ziv-aflibercept in metastatic colorectal cancer
por: Patel, Anuj, et al.
Publicado: (2013)